Cartesian Therapeutics
RNAC
RNAC
65 hedge funds and large institutions have $66.5M invested in Cartesian Therapeutics in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
-7
Holders Change %
-9.72%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
22
Reduced
19
Closed
13
Calls
$632K
Puts
–
Net Calls
+$632K
Net Calls Change
+$632K
Top Buyers
Top Sellers
1 |
![]()
JPMorgan Chase & Co
New York
|
-$1.96M |
2 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$1.09M |
3 |
Citadel Advisors
Miami,
Florida
|
-$275K |
4 |
AA
ALPS Advisors
Denver,
Colorado
|
-$256K |
5 |
Goldman Sachs
New York
|
-$208K |